Energy (or, more specifically, energy consumption) is at the forefront in everyone's mind these days. Whether we are sensitive to the cost of fuel, to the electricity bill or to a dead cell phone ...
The customary approach to early-phase clinical trial design, where the focus is on identification of the maximum tolerated dose, is not always suitable for noncytotoxic or other targeted therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results